Results 171 to 180 of about 1,115,460 (261)

Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years. [PDF]

JNCI Cancer Spectr
Storandt MH, Teslow EA, Yu Y, Yilma B, Mahipal A, Jin Z.   +5 more
europepmc   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Mapping the Fine-Scale Aging Landscape of Young Chinese Women: A LOESS-Based Analysis of 45 Biophysical Skin Parameters. [PDF]

Clin Cosmet Investig Dermatol
Fan Y, Hu J, Shan S.
europepmc   +1 more source

Ages of Ages

Ages of Ages is for SATB a capella choir. It is inspired by text taken from the medieval Old Hispanic chant, León 8, fol. 273: Et non deficiet ex te vir qui compleat voluntatem meam; and León 8, fol. 88v: Gloria et honor patri et filio et spiritui sancto et nunc and semper et in saecula saeculorum. An English translation is used for this piece.
openaire   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Protein glycoxidation in neuropsychiatric disorders-from basic research to clinical practice. [PDF]

Redox Biol
Orlof W, Maciejczyk M.
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

School-age lung function after preterm birth: early-life determinants in a paediatric pulmonology cohort with comparison with NHANES. [PDF]

Thorax
Kelchtermans J, Rice JL, Aoyama BC, Collaco JM, McGrath-Morrow S.   +4 more
europepmc   +1 more source

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

Molecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard, Flavie Bénard, Eva Billat, Margaux Le Guyon, Victoria Maltret, Laura Merlet, Chloé Astrid Walter, Tony Avril, Eric Chevet   +8 more
wiley   +1 more source

Chuangling Ye mitigates diabetic foot ulcer through suppressing keratinocyte ferroptosis via inhibiting ACSS2/ACSL4 axis. [PDF]

Chin Med
Feng X, Yi N, Zhang C, Tang L, Yin X, Zhao Y, Zhu T, Zhu J, Feng Q, Chen W, Xia Y, Ma C.   +11 more
europepmc   +1 more source